Maxlinear Inc
NASDAQ:MXL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.1
25.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Maxlinear Inc
Wall Street
Price Targets
MXL Price Targets Summary
Maxlinear Inc
According to Wall Street analysts, the average 1-year price target for
MXL
is 19.89 USD
with a low forecast of 14.14 USD and a high forecast of 27.3 USD.
MXL Last Price Targets
Maxlinear Inc
The latest public price target was made on Oct 24, 2024 by
Richard Shannon
from
Craig-Hallum
,
who expects
MXL
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Richard Shannon
Craig-Hallum
|
25
USD
Upside 31% |
1 month ago
Oct 24, 2024
|
MaxLinear (MXL) PT Lowered to $25 at Craig-Hallum
StreetInsider
|
Christopher Rolland
Susquehanna
|
15
USD
Downside 21% |
2 months ago
Oct 1, 2024
|
MaxLinear downgraded to Neutral from Positive at Susquehanna
TheFly
|
|
Richard Shannon
Craig-Hallum
|
28
USD
Upside 47% |
4 months ago
Jul 25, 2024
|
MaxLinear (MXL) PT Lowered to $28 at Craig-Hallum
StreetInsider
|
Tore Svanberg
Stifel Nicolaus
|
30
USD
Upside 57% |
5 months ago
Jul 18, 2024
|
MaxLinear price target raised to $30 from $26 at Stifel
TheFly
|
|
Tore Svanberg
Stifel Nicolaus
|
26
USD
Upside 36% |
6 months ago
Jun 6, 2024
|
Stifel Reiterates Buy Rating on MaxLinear (MXL)
StreetInsider
|
David Williams
Williams Trading
|
28
USD
Upside 47% |
8 months ago
Apr 15, 2024
|
MaxLinear (MXL) PT Raised to $28 at Benchmark
StreetInsider
|
Tim Savaggeaux
Northland Securities
|
30
USD
Upside 57% |
8 months ago
Apr 4, 2024
|
Northland Upgrades MaxLinear (MXL) to Outperform 'on AI Connectivity Growth Potential'
StreetInsider
|
Unknown Analyst
Needham
|
48
USD
Upside 152% |
1 year ago
Feb 2, 2023
|
Needham Maintains Buy on MaxLinear, Lowers Price Target to $48
Benzinga
|
|
Unknown Analyst
Susquehanna
|
48
USD
Upside 152% |
1 year ago
Feb 2, 2023
|
Susquehanna Maintains Positive on MaxLinear, Raises Price Target to $48
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MXL's stock price target?
Price Target
19.89
USD
According to Wall Street analysts, the average 1-year price target for
MXL
is 19.89 USD
with a low forecast of 14.14 USD and a high forecast of 27.3 USD.
What is Maxlinear Inc's Revenue forecast?
Projected CAGR
-3%
For the last 8 years the
compound annual growth rate for
Maxlinear Inc's revenue is
11%.
The projected
CAGR
for the next 4 years is
-3%.
You don't have any saved screeners yet
